- You can view the full Bristol-Myers Squibb Company Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Value stocks haven't done well in the era of easy money, with cash piling into growth names. But, that could be about to change.
Pfizer's CEO Ian Read could make almost $28 million in the next year to keep him from retiring. Strangely enough, he may earn it given the healthcare and political environment.
Sensing an opportunity, investors raced to eat up several big-cap stocks in February. Here are the biggest buys.
Jim Cramer takes a look at Square, Manitowoc, Valley National Bancorp, FMC Corp., Universal Display, CIT Group, Oneok, and Albemarle.